SA has a two part series on Omeros, a small cap biotech that has two major products in the pipeline that could result in significant upside for the company. Part 1 is here and part 2 is here.
The Fool is bullish on them as well, calling the company the "best buy in biotech."
November 28, 2017
November 3, 2017
Gannon's New Stock Position
Geoff Gannon's new stock position is in NACCO Industries after it was recently spun off. You can read the full post here.
Subscribe to:
Posts (Atom)